May 22, 2025, 22:58

MRC Infections and Immunity – New Investigator Grant

The Medical Research Council (MRC) invites early-career researchers to apply for a New Investigator Grant in the area of infections and immunity. This grant supports the transition to independence by funding research that deepens understanding of human infectious diseases and immune-related disorders. Applicants must demonstrate leadership potential, a compelling research plan, and alignment with the Infections and Immunity Board (IIB) remit.

Eligibility Criteria:

Must be hosted by an MRC-eligible UK research organisation
Applicants should be in the transition to independence stage
Cannot have previously held a substantial grant (typically ≥3 years and salary for staff)
Cannot have held a transition award or applied more than twice for an MRC new investigator grant
Can be non-clinical or clinically active
International researchers can be included as project co-leads, not as lead applicants
Applicants from MRC Unit The Gambia or MRC/UVRI Uganda are eligible

Research Areas Supported:

Human pathogens (bacterial, viral, fungal, parasitic)
Immunology and inflammation
Immune-mediated disease and multimorbidity
Vaccines and vaccinology
Antimicrobial resistance
Chronic infections and co-infections
Epidemiology and transmission
Biomarkers, diagnostics, and therapeutics

Funding Details:

No cap on total budget; typical full economic cost under £1 million
MRC funds 80% of full economic cost and 100% of permitted exceptions
Supports up to 50% of applicant’s salary
Includes staffing, travel, consumables, equipment, international co-lead costs (capped at 30% for high-income countries), and public engagement
Does not fund clinical treatment trials, PhD studentships, or bridging grants

Project Duration:

Typically 3 years (longer durations must be justified)
Projects must start 1–6 months after funding decision

Deadline:

4 September 2025 at 4:00 PM UK time

Where to Go for Further Information:

Official Page: https://www.ukri.org/opportunity/infections-and-immunity-new-investigator-grant

Scientific Queries: [email protected]

Technical Queries: [email protected]

antimicrobial resistance cancer early-career research human pathogens immune-mediated disease immunology infections and immunity infectious disease inflammation mrc new investigator OncoDaily Oncology vaccine research

How Artificial Intelligence Is Transforming Cancer Care in 2025: Diagnosis, Treatment, Clinical Trials, and Screening

Inside ASCO25 Exhibition - Who did it the best?

Douglas Flora: Fighting Cancer with Heart

Eric Small: Deeply Honored to Step Into the Role of 2025-26 ASCO President

Cyril Konto: I Trademarked The Word ‘Multispecific’ The Day I Arrived